1[3]Fruberg CD, Adams HP, Applegate WB, et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Circulation, 1994,90:1679
2[4]Blankenhorn DH, Selzer RH, Crawford DW,et al. Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two-and four-year reduction of intima-media thickness measured by ultrasound. Circulation,1993,88:20
3[2]Mack WJ, Hodis HN, Pogoda JM, et al. Reduction of carotid artery intima-media thickness with lipid lowering therapies: A comparison of two clinical trials. J Am Coll Cardiol 1993,21:166A
4Tangirala RK, Rubin EM, Palinski W. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein Edeficient mice. J Lipid Res, 1995,36:2320-2328.
5Lusis AJ. Atherosclerosis. Nature, 2000, 407:233-241.
6Weintraub WS, Harrison DG. C-reactive protein, inflammation and atherosclerosis: do we really understand it yet? Eur Heart J, 2000, 21 : 958-960.
7Belton O, Byrne D, Kearney D, et al. Cyclooxygenase-1 and - 2-dependent prostacyclin formation in patients with atherosclerosis. Circulation, 2000, 102: 840-845.
8Paul A, Calleja L, Camps J, et al. The continuous asministration of aspirin attenuates atherosclerosis in apolipoprotein E-deficient mice. Life Sci, 2000, 68 :457-465.
9Voisard R, Fisher R, Obwald M, et al. Aspirin (5mmol/L) inhibits leukocyte attack and triggered reactive cell proliferation in a 3D human coronary in vitro model. Circulation, 2001, 103:1688-1694.
10Pratico D, Tillmann C, Zhang Z, et al. Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice. PNAS, 2001, 98:3358-3363.
